- Filed
- Mar 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 18, 2026 | 5.78M sh |
| Capex | FY 2025 · Dec 31, 2025 | $518K |
| Capex | FY 2025 · Dec 31, 2024 | $36K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$4.99M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$18.38M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $137.53M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $55.29M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $35.27M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $17.6M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $36.83M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $56.27M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $27.26M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $119.41M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $53.48M |
| Current Assets | FY 2025 · Dec 31, 2025 | $145.03M |
| Current Assets | FY 2025 · Dec 31, 2024 | $60.23M |
| Total Assets | FY 2025 · Dec 31, 2025 | $154.69M |
| Total Assets | FY 2025 · Dec 31, 2024 | $71.08M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$4.19 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$15.24 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$4.19 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$15.24 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $29.71M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $24.78M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $56.04M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $41.21M |
| Net Income | FY 2025 · Dec 31, 2025 | −$35.04M |
| Net Income | FY 2025 · Dec 31, 2024 | −$58.24M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$41.98M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$60.58M |
| Revenue | FY 2025 · Dec 31, 2025 | $43.77M |
| Revenue | FY 2025 · Dec 31, 2024 | $6.34M |